Showing 421 - 440 results of 550 for search '"pharmacy"', query time: 0.05s Refine Results
  1. 421
  2. 422

    Treatment Interruption and Regimen Change in Firstgeneration versus Second-generation Tyrosine Kinase Inhibitors used as First-line Therapy for Chronic Myeloid Leukemia by Melea A. Ward, Gang Fang, Kristy L. Richards, Christine M. Walko, Stephanie R. Earnshaw, Laura E. Happe, Susan J. Blalock

    Published 2015-04-01
    “…Treatment interruption was defined as a gap in any TKI pharmacy claim that was longer than an allowable refill gap plus days’ supply from the previous TKI medication claim. …”
    Get full text
    Article
  3. 423
  4. 424
  5. 425

    Healthcare Resource Utilization Among Patients With Agitation in Alzheimer Dementia by Christie Teigland, Zulkarnain Pulungan, David Bruhn, Steve Hwang

    Published 2024-10-01
    “…**Methods:** Medicare beneficiaries from 100% of the Medicare Fee-for-Service claims database (2009-2016) with 2 or more claims 30 or more days apart for both Alzheimer’s disease and dementia and continuous enrollment with medical/pharmacy coverage for 6 months before and 12 months after the index diagnosis were included. …”
    Get full text
    Article
  6. 426

    Medical Resource Use and Costs of Treating Sickle Cell-related Vaso-occlusive Crisis Episodes: A Retrospective Claims Study by Nirmish Shah, Menaka Bhor, Lin Xie, Jincy Paulose, Huseyin Yuce

    Published 2020-06-01
    “…Patients were required to have continuous medical and pharmacy benefits for 6 months pre- and 12 months post-index. …”
    Get full text
    Article
  7. 427
  8. 428
  9. 429
  10. 430

    Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease by Christopher M. Blanchette, Şerban R. Iorga, Aylin Altan, Jerry G. Seare, Ying Fan, Sandro Rossetti, Benjamin Gutierrez

    Published 2014-07-01
    “…**Methods:** Patients diagnosed with ADPKD (two or more claims) with ≥30 days of continuous medical and pharmacy benefits and no evidence of autosomal recessive polycystic kidney disease were selected (Optum Research Database and Impact National Benchmarking Database: 1/1/06–8/31/12). …”
    Get full text
    Article
  11. 431
  12. 432

    Background and Foreground: Connections and Distinctions When Health Professions Faculty Teach Both Interprofessional Collaborative Practice and Quality Improvement—A Case Study by Katherine Stevenson, Johan Thor, Marcel D’Eon, Linda A Headrick, Boel Andersson Gäre

    Published 2025-02-01
    “…Eleven faculty members from medicine, nursing, pharmacy, and health care administration participated in interviews exploring their teaching choices in either classroom or clinical settings. …”
    Get full text
    Article
  13. 433
  14. 434
  15. 435
  16. 436
  17. 437

    An assessment of South African policy and strategic framework for the development of a sufficient, equitably distributed and well-performing health workforce for the implementation... by S V Mokoena, P Naidoo

    Published 2025-02-01
    “…They were individuals and stakeholders who interact with and/or are in the employment of statutory health councils, regulatory bodies, medical aid administrators, medical schemes, voluntary bodies/organisations and healthcare workers who are registered with the SA Pharmacy Council, Health Professions Council of SA and SA Nursing Council. …”
    Get full text
    Article
  18. 438
  19. 439
  20. 440